Orange Book product
NAPROXEN SODIUM EQ 500MG BASE
Orange Book ANDA 212199 · SCIEGEN PHARMACEUTICALS INC · Prescription
Key facts
| Proprietary name | NAPROXEN SODIUM |
|---|---|
| Active ingredients | NAPROXEN SODIUM |
| Strength | EQ 500MG BASE |
| Dosage form | TABLET |
| Route | ORAL |
| Application | ANDA212199 |
| Applicant holder | SCIEGEN PHARMACEUTICALS INC |
| Marketing status | Prescription |
| Therapeutic equivalence (TE) code | AB |
| Reference listed drug (RLD) | No |
| Reference standard (RS) | No |
| Approval date | Oct 30, 2019 |
At a glance
- 1–9 Marketed products with the same ingredient, strength and form
- 1–9 Products in this application
- No Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.